US Nuclear Corp. (UCLE)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
US Nuclear Corp. (UCLE) ist im Technology-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 49/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026US Nuclear Corp. (UCLE) Technologieprofil & Wettbewerbsposition
US Nuclear Corp. specializes in radiation detection and measurement equipment, offering solutions for nuclear facilities, hospitals, and security applications. Operating through its Optron and Overhoff segments, the company provides monitors, detectors, and software for diverse industries, facing competition in a specialized market.
Investmentthese
US Nuclear Corp. operates in a niche market with increasing demand for radiation detection equipment, driven by growing concerns over nuclear safety and security. The company's diverse product line, serving multiple industries, provides revenue streams. With a negative profit margin of -82.9% and a significantly negative ROE of -407052.9%, the company faces challenges in achieving profitability. The company's high debt-to-equity ratio of 518.15 also presents a risk. Investors should carefully consider these financial metrics and the company's ability to improve its financial performance.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Gross Margin of 42.1% indicates a solid ability to generate revenue from sales, before considering operating expenses.
- Negative Profit Margin of -82.9% reflects significant challenges in achieving profitability, suggesting high operating costs or low sales volume.
- ROE of -407052.9% indicates extremely poor return on equity, suggesting inefficient use of shareholder investments.
- Debt-to-Equity Ratio of 518.15 indicates a high level of financial leverage, which could pose risks if the company faces difficulties in meeting its debt obligations.
- Beta of -1.83 suggests the stock price is negatively correlated with the market, potentially offering diversification benefits but also indicating unique risk factors.
Staerken
- Diverse product line catering to multiple industries.
- Strategic alliance with Arbok-Nuclear for specialized solutions.
- Established presence in the radiation detection market.
- Offers both hardware and software solutions.
Schwaechen
- Negative profit margin and ROE indicate financial instability.
- High debt-to-equity ratio poses financial risk.
- Small market capitalization limits access to capital.
- OTC market listing may reduce investor confidence.
Katalysatoren
- Ongoing: Increasing global concerns over nuclear safety and security driving demand for radiation detection equipment.
- Ongoing: Strategic alliance with Arbok-Nuclear potentially leading to new market opportunities in rad-wastewater treatment.
- Upcoming: Potential government contracts for port security equipment.
- Upcoming: Development and launch of next-generation handheld survey meters and dosimeters.
- Ongoing: Expansion of DroneRAD aerial radiation detection systems into new markets.
Risiken
- Ongoing: Negative profit margin and ROE indicate financial instability.
- Potential: High debt-to-equity ratio poses financial risk.
- Potential: Intense competition from established players in the radiation detection market.
- Potential: Stringent regulatory requirements and compliance costs.
- Ongoing: OTC market listing may reduce investor confidence and liquidity.
Wachstumschancen
- Expansion of DroneRAD Aerial Radiation Detection Systems: The market for drone-based radiation detection is growing, driven by the need for rapid and comprehensive monitoring in emergency situations and large-scale environmental assessments. US Nuclear Corp.'s DroneRAD system can be marketed to government agencies, environmental organizations, and nuclear facilities. This market is estimated to reach $500 million by 2030, presenting a significant growth opportunity.
- Development of Advanced Radiation Water Monitoring Solutions: With increasing concerns about water contamination from nuclear accidents and industrial activities, there is a growing demand for advanced radiation water monitoring systems. US Nuclear Corp. can capitalize on this trend by developing and marketing highly sensitive and reliable water monitors for use in drinking water facilities, industrial plants, and environmental monitoring programs. The global water quality monitoring market is projected to reach $4 billion by 2028.
- Strategic Alliances for Rad-Wastewater Treatment: The strategic alliance with Arbok-Nuclear for desalination and rad-wastewater treatment techniques presents an opportunity to expand into the environmental remediation market. By offering comprehensive solutions for treating radioactive wastewater, US Nuclear Corp. can tap into the growing demand for effective and sustainable waste management technologies. The rad-wastewater treatment market is expected to reach $2 billion by 2027.
- Penetration of the Port Security Equipment Market: The increasing need for enhanced security measures at ports and borders drives the demand for advanced detection equipment. US Nuclear Corp. can expand its market share by offering port security equipment, including vehicle, personnel, and cargo monitors, to government agencies and security organizations. The global port security market is projected to reach $35 billion by 2029.
- Development of Next-Generation Handheld Survey Meters and Dosimeters: The market for handheld survey meters and personal dosimeters is driven by the need for portable and reliable radiation detection tools in various industries, including nuclear power, healthcare, and emergency response. US Nuclear Corp. can maintain its competitive edge by developing next-generation devices with enhanced sensitivity, improved ergonomics, and advanced data logging capabilities. The global radiation detection market is expected to reach $18 billion by 2028.
Chancen
- Expansion of DroneRAD aerial radiation detection systems.
- Development of advanced radiation water monitoring solutions.
- Penetration of the port security equipment market.
- Growth in the rad-wastewater treatment market through strategic alliances.
Risiken
- Intense competition from established players in the radiation detection market.
- Stringent regulatory requirements and compliance costs.
- Technological advancements may render existing products obsolete.
- Economic downturns may reduce demand for radiation detection equipment.
Wettbewerbsvorteile
- Specialized Product Portfolio: Focus on niche radiation detection and measurement market.
- Strategic Alliance: Partnership with Arbok-Nuclear for desalination and rad-wastewater treatment.
- Diverse Customer Base: Serves multiple industries, including nuclear, healthcare, and security.
- Established Product Line: Offers a range of monitors, detectors, and software solutions.
Ueber UCLE
US Nuclear Corp., headquartered in Canoga Park, California, develops, manufactures, and sells radiation detection and measuring equipment globally. The company operates through two segments: Optron and Overhoff. Its product line includes radiation water monitors, designed to detect radioactive materials in various water sources, and alpha, beta, gamma, neutron, and Tritium monitors. The company also offers DroneRAD aerial radiation detection systems, air and water monitors, and nano-second X-ray monitors. US Nuclear Corp. provides vehicle, personnel, exit, and room monitors, as well as radon air monitors and radon switch products used to determine radon content in air. Their offerings extend to handheld survey meters, personal dosimeters, pocket micro-R meters, and port security equipment. The company provides software solutions that measure gamma and neutron radiation levels, airborne radioactivity levels, temperature, humidity, security door status, wind speed, direction, and barometric pressure. US Nuclear Corp.'s products and services cater to nuclear reactor plants, universities, hospitals, government agencies, and emergency responders. They also serve airports, cargo screening facilities, ports, borders, government buildings, and other critical infrastructure. The company has a strategic alliance with Arbok-Nuclear to introduce desalination and rad-wastewater treatment techniques, reflecting its commitment to addressing environmental concerns related to nuclear materials.
Was das Unternehmen tut
- Develops radiation water monitors for detecting radioactive materials in water sources.
- Manufactures alpha, beta, gamma, neutron, and Tritium monitors.
- Offers DroneRAD aerial radiation detection systems.
- Provides air and water monitors for environmental monitoring.
- Produces nano-second X-ray monitors for specialized applications.
- Supplies vehicle, personnel, exit, and room monitors for security purposes.
- Offers radon air monitors and radon switch products for radon detection.
- Develops handheld survey meters, personal dosimeters, and pocket micro-R meters.
Geschaeftsmodell
- Sells radiation detection and measuring equipment to various industries.
- Generates revenue through the Optron and Overhoff segments.
- Provides software solutions for radiation monitoring and data analysis.
- Forms strategic alliances for technology development and market expansion.
Branchenkontext
US Nuclear Corp. operates within the scientific and technical instruments industry, which is experiencing growth due to increasing demand for advanced detection and monitoring technologies. The market is driven by stringent safety regulations, growing environmental concerns, and the need for enhanced security measures. Competition includes companies specializing in radiation detection, environmental monitoring, and security solutions. US Nuclear Corp.'s focus on radiation detection and its strategic alliance with Arbok-Nuclear position it to capitalize on the growing demand for specialized solutions.
Wichtige Kunden
- Nuclear reactor plants
- Universities and research institutions
- Local and state hospitals
- Government agencies
- Emergency medical technicians and first responders
- Airports, cargo screening facilities, ports, and borders
Finanzdaten
Chart & Info
US Nuclear Corp. (UCLE) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer UCLE verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer UCLE.
Kursziele
Wall-Street-Kurszielanalyse fuer UCLE.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von UCLE auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Klassifizierung
Branche Scientific & Technical InstrumentsUCLE OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, encompassing companies that may not meet the minimum financial standards or disclosure requirements of the higher tiers like OTCQX and OTCQB. Companies in this tier may be newly formed, distressed, or have limited operating history. Investing in companies on the OTC Other tier carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in these companies.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited regulatory oversight and disclosure requirements.
- Potential for fraud and market manipulation.
- High price volatility due to low trading volume.
- Difficulty in obtaining reliable financial information.
- Increased risk of delisting or trading suspension.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Evaluate the company's business model and revenue streams.
- Determine the company's ownership structure and potential conflicts of interest.
- Consult with a qualified financial advisor.
- Established product line in radiation detection equipment.
- Strategic alliance with Arbok-Nuclear.
- Serves multiple industries, including nuclear, healthcare, and security.
- Headquartered in the United States.
US Nuclear Corp. Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for UCLE?
US Nuclear Corp. (UCLE) currently holds an AI score of 49/100, indicating low score. Key strength: Diverse product line catering to multiple industries.. Primary risk to monitor: Ongoing: Negative profit margin and ROE indicate financial instability.. This is not financial advice.
How frequently does UCLE data refresh on this page?
UCLE prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven UCLE's recent stock price performance?
Recent price movement in US Nuclear Corp. (UCLE) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product line catering to multiple industries.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider UCLE overvalued or undervalued right now?
Determining whether US Nuclear Corp. (UCLE) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying UCLE?
Before investing in US Nuclear Corp. (UCLE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding UCLE to a portfolio?
Potential reasons to consider US Nuclear Corp. (UCLE) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diverse product line catering to multiple industries.. Additionally: Strategic alliance with Arbok-Nuclear for specialized solutions.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of UCLE?
Yes, most major brokerages offer fractional shares of US Nuclear Corp. (UCLE) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track UCLE's earnings and financial reports?
US Nuclear Corp. (UCLE) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for UCLE earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is limited due to the company's OTC listing.
- Analyst coverage is not available for UCLE.